Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksActiveops Regulatory News (AOM)

Share Price Information for Activeops (AOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 101.00
Bid: 100.00
Ask: 102.00
Change: -3.00 (-2.88%)
Spread: 2.00 (2.00%)
Open: 101.00
High: 101.00
Low: 101.00
Prev. Close: 104.00
AOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Half Year Results

18 Oct 2023 07:00

RNS Number : 4484Q
ActiveOps PLC
18 October 2023

18 October 2023

ActiveOps plc

("ActiveOps" or the "Company")

Trading Update

and Notice of Half Year Results

Group continues to deliver solid growth and is trading in line with expectations

ActiveOps plc (AIM: AOM), a leading provider of Decision Intelligence for service operations, today provides an update on trading for the six months ended 30 September 2023. The Board is pleased to report continued growth in the first half of FY24, with the Group well-placed to achieve both its revenue and EBITDA expectations for the full year.

The Group expects to report overall revenue growth of approximately 6% to c.£13.1m (H1 2023: £12.3m), and significant EBITDA growth (H1 2023: £0.3m).

SaaS revenues in the period were up over 7%, driving a 7% growth in exit Annual Recurring Revenue (ARR) to c.£23.7m (September 2022: £22.1m), providing a firm foundation for the full year performance.

Through prudent management of the business, the Group remains well capitalised with cash and cash equivalents as at 30 September 2023 of £9.9m (September 2022: £11.0m), with a further £3.3m received from customers in early October 2023.

The Group has successfully executed against its land and expand strategy, winning new customers, along with good levels of customer expansion sales across all three products, facilitated by the demonstrable and rapid benefits the products bring.

The Group is seeing customer appetite to take new product continuing to build. The launch of ControliQ Series 3, with its AI-based features, has been particularly well received by customers. Our product teams are harnessing the latest advances in technology to help our customers better organise, see capacity clearer and ultimately improve performance for their own customers.

The first of ActiveOps' 2023 annual customer conferences was held in London on the 10 October. Here the Company successfully launched its new brand, focused on the provision of Decision Intelligence for Service Operations. The Group's products help customers improve their decision making and do more with what they have. The message, that ActiveOps' products help create more capacity and enhance productivity to improve customer experience, while reducing costs, is resonating well across the Group's customer base and target markets. Expected total attendance across the Company's customer conferences is up 25% vs last year, reflecting its strong customer relationships and the interest in the Group's solutions.

Notice of Results

The Company intends to announce its results for the six months ended 30 September 2023 on 14 November 2023.

Richard Jeffery, Chief Executive Officer of ActiveOps plc, commented, "The ActiveOps team continues to deliver against our clear growth strategy despite wider macroeconomic uncertainty. High recurring revenues, strong gross margins, low churn rates and a strong balance sheet give the Group confidence as it looks ahead to the remainder of the year.

"The demonstrable value of our product set is resonating well with our blue-chip enterprise customer base, which, when coupled with our strong customer relationships, underpins the success of the Group. With the release of ControliQ Series 3 and soon to be released Series 4, our product set is becoming increasingly sophisticated and intelligent. With further enhancements to our product roadmap on the horizon, each with decision intelligence at their core, we continue to upgrade the tools our customers have available to them, protecting our reputation as market leaders in the management process automation market.

"With growth against all of our key KPIs, good levels of renewals, and a healthy pipeline, we remain on track for a full year in line with Board expectations."

For more information, please contact:

ActiveOps

Via Alma

Richard Jeffery, Chief Executive Officer

www.activeops.com

Ken Smith, Chief Financial Officer

?

?

?

Investec Bank plc

+44 (0)20 7597 5970

Corporate Broking & PLC Advisory

?

Patrick Robb / David Anderson

?

?

?

Alma

+ 44(0) 203 405 0205

Caroline Forde / Will Ellis Hancock

About ActiveOps

The Company's offerings provide predictive and prescriptive insight to help service operations make better decisions - faster. The Company's AI-powered SaaS solutions are underpinned by 15+ years of operational data and its AOM methodology that's proven to drive cross department decision-making.

With Decision Intelligence, ActiveOps' customers deliver MORE - release 20%+ capacity within the first 12 months and boost productivity by 30%+ leading to MORE business impact. Customer turnaround times are improved substantially, costs are reduced, SLAs are met, and employees are happier and more engaged.

As at 31 March 2023, The Company has over 170 employees, serving a global customer base of over 80 enterprise customers from offices in the UK, Ireland, USA, Australia, India and South Africa. The Group's customers are predominantly in the banking, insurance, healthcare administration and business process outsourcing (BPO) sectors, including Nationwide, TD Bank, Elevance and DXC Technology.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTMRBMTMTTBTRJ
12
Date   Source Headline
27th Feb 20237:00 amRNSDirector/PDMR Dealing
20th Feb 202310:38 amRNSDirector/PDMR Dealing
24th Jan 20231:27 pmRNSDirector/PDMR Dealing
18th Jan 202311:18 amRNSDirector/PDMR Dealing
29th Dec 202212:48 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
16th Dec 20227:00 amRNSDirectorate Change
7th Dec 20225:38 pmRNSHolding(s) in Company
1st Dec 202212:01 pmRNSHolding(s) in Company
29th Nov 20227:00 amRNSInterim Results
25th Nov 202210:12 amRNSDirector/PDMR Dealing
21st Nov 202211:28 amRNSDirector/PDMR Dealing
2nd Nov 20221:47 pmRNSHolding(s) in Company
25th Oct 20227:00 amRNSTrading Update and Notice of Half Year Results
24th Oct 20223:57 pmRNSDirector/PDMR Dealing
19th Oct 20223:29 pmRNSDirector/PDMR Dealing
29th Sep 20223:32 pmRNSResult of AGM
15th Sep 202212:31 pmRNSDirector/PDMR Dealing
7th Sep 20227:00 amRNSUK bank signs contract for CaseworkiQ
8th Aug 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSResults for the year ended 31 March 2022
27th Jun 20227:00 amRNSNotice of Results
6th Jun 20227:00 amRNSActiveOps launches CaseworkiQ RegTech Solution
31st May 202212:00 pmRNSHolding(s) in Company
23rd May 202210:23 amRNSHolding(s) in Company
30th Mar 202212:08 pmRNSDirector/PDMR Shareholding
29th Mar 202212:32 pmRNSDirector/PDMR Shareholding
28th Mar 20225:29 pmRNSDirector/PDMR Shareholding
25th Mar 202211:43 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSTrading Update
22nd Mar 20224:53 pmRNSTotal Voting Rights
22nd Mar 202212:42 pmRNSBlock listing Interim Review
28th Jan 20225:49 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSInterim Results
27th Oct 202110:30 amRNSHolding(s) in Company
20th Oct 20217:00 amRNSTrading Update and Notice of Results
30th Sep 20211:38 pmRNSResult of AGM
29th Sep 20217:00 amRNSContract wins and expansions at largest customers
24th Aug 202111:12 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20217:00 amRNSDirector/PDMR Shareholding
22nd Jul 20217:00 amRNSFinal Results
20th Jul 20217:00 amRNSNotice of Results
7th Jun 20214:56 pmRNSBlocklisting Application
31st Mar 20213:45 pmRNSHolding(s) in Company
31st Mar 20213:41 pmRNSHolding(s) in Company
30th Mar 20214:07 pmRNSHolding(s) in Company
30th Mar 20211:17 pmRNSDirector/PDMR Shareholding
29th Mar 20217:00 amRNSAdmission to AIM and First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.